XML 41 R31.htm IDEA: XBRL DOCUMENT v3.21.2

REVENUE (Tables)

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation of revenue

The following table presents the Company’s revenues disaggregated by revenue source:

						Three Months Ended September 30,												Nine Months Ended September 30,
(In thousands)						2021						2020						2021						2020
Screening
Medicare Parts B & C						$	116,088					$	98,847					$	329,034					$	256,589
Commercial						151,245						106,002						419,268						280,451
Other						13,045						9,774						36,341						28,367
Total Screening						280,378						214,623						784,643						565,407
Precision Oncology
Medicare Parts B & C						$	51,607					$	33,945					$	142,428					$	114,973
Commercial						42,844						37,402						145,821						137,212
International						27,229						16,243						80,133						56,227
Other						23,732						3,989						44,246						14,493
Total Precision Oncology						145,412						91,579						412,628						322,905
COVID-19 Testing						$	30,589					$	102,161					$	96,004					$	136,740
Total						$	456,379					$	408,363					$	1,293,275					$	1,025,052

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration